OPAT outcomes in endocarditis

BMJ (Online)

Volumn 346, Issue 7905, 2013, Pages

  Duncan, Christopher J A ^a,b   Barr, David A ^b   Seaton, R Andrew ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; TEICOPLANIN;

BACTERIAL ENDOCARDITIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG TREATMENT FAILURE; HEALTH PROGRAM; HEART FAILURE; HUMAN; KIDNEY FAILURE; LETTER; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT ASSESSMENT; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; HUMANS; INFECTION;

EID: 84877629158     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f2484     Document Type: Letter

References (5)

1. Chapman AL. Outpatient parenteral antimicrobial therapy. BMJ 2013;346:f1585.
2. Chapman AL, Seaton RA, Cooper MA, Hedderwick S, Goodall V, Reed C, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 2012;67:1053-62.
3. Mackintosh CL, White HA, Seaton RA. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. J Antimicrob Chemother 2011;66:408-15.
4. Seaton RA, Sharp E, Bezlyak V, Weir CJ. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents 2011;38:243-8.
5. Duncan CJ, Barr DA, Ho A, Sharp E, Semple L, Seaton RA. Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis. J Antimicrob Chemother 2013; published online 8 Mar.